MILNE GEORGE M JR

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 40% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
MILNE GEORGE M JR's trades of Amylyx Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
33.60
Quantity 35,000
Value US$1,176,000
Transaction date
Purchase
Price
19.00
Quantity 26,315 +13.5%
Value US$499,985
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-07 2026-10-05
PlS Planned sale
36,763 -23.4%
142.61
US$4,074,575 		36,763 -23.4% 142.61 US$4,074,575
2026-10-05 2026-10-05
PrS Proposed sale
79,588
49.58
US$4,375,082 		79,588 49.58 US$4,375,082
2024-09-05 2024-09-03
B Purchase
99,500 +7.3%
274.21
US$3,197,141 		99,500 +7.3% 274.21 US$3,197,141
2023-03-20 2023-03-16
PlS Planned sale
1,916 -0.2%
32.45
US$62,172 		1,916 -0.2% 32.45 US$62,172
2023-03-20 2023-03-16
PlS Planned sale
33,084 -3.7%
31.86
US$1,053,901 		33,084 -3.7% 31.86 US$1,053,901
2023-03-16 2023-03-16
PrS Proposed sale
35,000
33.60
US$1,176,000 		35,000 33.60 US$1,176,000
2023-03-06 2023-03-02
B Purchase
20,000 +40.0%
8.91
US$178,284 		20,000 +40.0% 8.91 US$178,284
2022-03-08 2022-03-04
B Purchase
5,000 +11.1%
10.82
US$54,100 		5,000 +11.1% 10.82 US$54,100
2022-01-10 2022-01-06
B Purchase
26,315 +13.5%
19.00
US$499,985 		26,315 +13.5% 19.00 US$499,985
2021-03-09 2021-03-05
B Purchase
5,000 +12.5%
13.00
US$65,000 		5,000 +12.5% 13.00 US$65,000
2021-03-02 2021-03-01
S Sale
3,530 -11.0%
290.01
US$1,023,730 		3,530 -11.0% 290.01 US$1,023,730
2020-02-19 2020-02-18
S Sale
7,170 -21.0%
176.07
US$1,262,430 		7,170 -21.0% 176.07 US$1,262,430
2019-02-25 2019-02-22
S Sale
4,540 -15.7%
143.00
US$649,220 		4,540 -15.7% 143.00 US$649,220